Align Technology (ALGN)
(Delayed Data from NSDQ)
$233.97 USD
+5.28 (2.31%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $233.76 -0.21 (-0.09%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum D VGM
Align Technology (ALGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$292.00 | $370.00 | $215.00 | 27.68% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Align Technology comes to $292.00. The forecasts range from a low of $215.00 to a high of $370.00. The average price target represents an increase of 27.68% from the last closing price of $228.69.
Analyst Price Targets (11)
Broker Rating
Align Technology currently has an average brokerage recommendation (ABR) of 1.96 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.96 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, seven are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 58.33% and 8.33% of all recommendations. A month ago, Strong Buy made up 58.33%, while Buy represented 8.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ALGN.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/22/2024 | UBS | Kevin Caliendo | Hold | Hold |
7/22/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
7/9/2024 | SVB Securities | Michael Cherny | Hold | Hold |
7/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/21/2024 | Piper Sandler | Jason Bednar | Strong Buy | Strong Buy |
6/10/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
5/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/24/2024 | William Blair | Brandon Vazquez | Strong Buy | Strong Buy |
2/2/2024 | Goldman Sachs | Nathan Rich | Strong Sell | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.96 |
ABR (Last week) | 1.96 |
# of Recs in ABR | 12 |
Average Target Price | $292.00 |
LT Growth Rate | 5.80% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 188 of 253 |
Current Quarter EPS Est: | 2.33 |